GlassScriptPhysician profile
Gregory Paul Danielson
NPI 1326063678
$2,486.55
in general payments reported to CMS, 2019-2025
23 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $36.47 · 2021: $367 · 2022: $442 · 2023: $440 · 2024: $167 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.11 |
| Travel and Lodging | $103.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $385.35 | 2021-2025 | Inspire |
| Medtronic, INC. | $300.65 | 2023-2025 | Fusion, Pteye Parathyroid Detection System |
| Stryker Corporation | $289.98 | 2019-2022 | |
| Cochlear Americas | $242.44 | 2021-2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Aerin Medical INC. | $212.70 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $143.77 | 2019-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $118.48 | 2025 | Tezspire |
| Genzyme Corporation | $107.24 | 2019-2025 | |
| Preceptis Medical, INC. | $101.06 | 2025 | |
| Sanofi-Aventis U.S. LLC | $98.99 | 2022 | |
| Glaxosmithkline, LLC. | $92.41 | 2021-2025 | Nucala |
| Acclarent, INC | $71.28 | 2021 | |
| Intersect Ent, INC. | $70.95 | 2019-2022 | |
| Integra Lifesciences Corporation | $53.91 | 2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Smith+Nephew, INC. | $46.67 | 2024 | Tula |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $39.98 | 2024 | Watchpatone |
| Phathom Pharmaceuticals, INC. | $19.34 | 2024-2025 | Voquezna |
| Organogenesis INC. | $18.98 | 2024 | |
| Microtransponder, INC. | $18.30 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.73 | 2022 | |
| Merck Sharp & Dohme LLC | $14.71 | 2023 | |
| Kaleo, INC. | $11.45 | 2021 | |
| Optinose US, INC. | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Danielson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.